If the Therapeutic Goods Administration (TGA) determines that your medical device does not meet regulatory requirements, it’s essential to know how to handle TGA non-compliance issues. These findings may occur during audits, post-market reviews, or investigations into complaints. Non-compliance can lead to suspension, cancellation, or enforcement actions.
Here are some important corrective steps to take when dealing with non-compliance issues related to the TGA.
Identify and Assess the Problem
Review the TGA’s findings in detail to understand the scope of the non-compliance. Determine whether the issue relates to manufacturing processes, documentation, labelling, or performance. Clear identification allows you to target the cause rather than treating only the symptoms.
Develop a Corrective Action Plan
An effective way to handle TGA non-compliance issues is planning how to address them and prevent them from recurring. This may involve revising procedures, updating technical documentation, or conducting additional testing. The TGA may require evidence that these measures have been completed before closing the matter.
Ensure Effective Communication
Maintaining open communication with the TGA and your sponsor helps demonstrate your commitment to resolving the issue. Provide regular updates on your progress and respond promptly to any requests for further information.
Corrective Action Protects Market Access
The sooner you address the problem, the more likely you are to ensure fast TGA approval and protect your ability to supply in Australia. Understanding how to handle TGA non-compliance issues will help you respond effectively and minimise disruption.